Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhong Ji Longevity Science Group's quarterly market cap
increased
from Dec. 2024 (HK$123.0 Mil) to Jun. 2025 (HK$296.0 Mil) and
increased
from Jun. 2025 (HK$296.0 Mil) to Dec. 2025 (HK$318.3 Mil).
Zhong Ji Longevity Science Group's annual market cap
increased
from Dec. 2023 (HK$61.5 Mil) to Dec. 2024 (HK$123.0 Mil) and
increased
from Dec. 2024 (HK$123.0 Mil) to Dec. 2025 (HK$318.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zhong Ji Longevity Science Group's Enterprise Value for Today is HK$250.6 Mil.
Zhong Ji Longevity Science Group (HKSE:00767) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zhong Ji Longevity Science Group Market Cap Related Terms
Zhong Ji Longevity Science Group Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00767 vs TMO, DHR, IDXX: Market Cap Comparison
For the Diagnostics & Research subindustry, Zhong Ji Longevity Science Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhong Ji Longevity Science Group Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Zhong Ji Longevity Science Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Zhong Ji Longevity Science Group's Market Cap falls into.
Zhong Ji Longevity Science Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhong Ji Longevity Science Group (HKSE:00767) has a Market Cap of HK$229.2 Mil as of Aug. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zhong Ji Longevity Science Group and its competitors. According to the industry distribution chart, Zhong Ji Longevity Science Group ranks #139 out of 217 companies in the Medical Diagnostics & Research industry, placing it in the top 64.1%.
Is Zhong Ji Longevity Science Group's Market Cap too high?
Zhong Ji Longevity Science Group's current Market Cap is HK$229.2 Mil. Based on the distribution chart, Zhong Ji Longevity Science Group ranks #139 out of 217 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Zhong Ji Longevity Science Group has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhong Ji Longevity Science Group's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Zhong Ji Longevity Science Group ranks #139 out of 217 companies for Market Cap. This places Zhong Ji Longevity Science Group in the lower half of its industry. The industry median Market Cap is 60.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 60.11, based on 217 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zhong Ji Longevity Science Group and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 60.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhong Ji Longevity Science Group's current Market Cap is HK$229.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhong Ji Longevity Science Group stock overvalued right now?
Based on GuruFocus' analysis, Zhong Ji Longevity Science Group (HKSE:00767) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.89, compared to a current price of HK$0.36 — trading 59.6% below its estimated fair value. The current Market Cap is HK$229.2 Mil. Zhong Ji Longevity Science Group's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Zhong Ji Longevity Science Group (HKSE:00767), the current Market Cap is HK$229.2 Mil as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhong Ji Longevity Science Group (HKSE:00767) Overvalued in 2026?
Based on GuruFocus' analysis, Zhong Ji Longevity Science Group stock appears to be undervalued.
The current stock price of HK$0.36 is trading 59.6% below its estimated GF Value™ of HK$0.89.
GuruFocus considers Zhong Ji Longevity Science Group to be Possible Value Trap.
Key valuation signals for HKSE:00767:
Market Cap: HK$229.2 Mil
GF Value™: HK$0.89 vs. price of HK$0.36 (59.6% below fair value)
No single metric tells the full story. See the HKSE:00767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhong Ji Longevity Science Group Ltd is an investment holding company. Through its subsidiaries, it engages in Longevity science business, Money lending and Financial Advisory, Securities and other investments, and Property investment. The company generates the majority of its revenue from the Longevity Science business. The Longevity science business includes the provision of diagnostic consultation, health and medical testing and checking, distribution of cancer prevention & immunity healthcare supplements, and the sales and distribution of longevity wine.
55GF Score
Get the complete analysis for HKSE:00767
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00767 has been successfully added to your 
